Safety and Efficacy of Trastuzumab as Part of Breast Cancer Treatment Regimen
Clinical trial NCT02419742 · COMPLETED
Trial details
- NCT number
- NCT02419742
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2015-08-18
- Primary completion
- 2021-06-24
- Enrollment
- 110
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.